Literature DB >> 10485306

Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency.

P Labrune1, J Zittoun, I Duvaltier, P Trioche, J Marquet, P Niaudet, M Odièvre.   

Abstract

An 18-month-old girl presented with macrocytic megaloblastic anaemia followed by haemolytic uraemic syndrome. Metabolic investigations led to the identification of an inborn error of cobalamin metabolism consisting of defective methylcobalamin biosynthesis, probably cobalamin G, since methionine synthase activity was decreased under standard reducing conditions. Despite treatment, pulmonary hypertension progressively developed and responded to oxygen therapy. Renal involvement evolved to terminal failure and haemodialysis, while pulmonary hypertension was controlled by oxygen therapy. Such clinical manifestations have never been reported in association with a defect of methylcobalamin and thus of methionine biosynthesis. A congenital abnormality of cobalamin metabolism was suspected then confirmed in the presence of typical haematological features associated with unusual clinical manifestations such as progressive renal failure and pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485306     DOI: 10.1007/s004310051190

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  12 in total

1.  Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls.

Authors:  Maria Helena Vaisbich; Andressa Braga; Maria Gabrielle; Clarissa Bueno; Flávia Piazzon; Fernando Kok
Journal:  Pediatr Nephrol       Date:  2017-02-16       Impact factor: 3.714

2.  cblE-Type Homocystinuria Presenting with Features of Haemolytic-Uremic Syndrome in the Newborn Period.

Authors:  Daniel Palanca; Angels Garcia-Cazorla; Jessica Ortiz; Cristina Jou; Victoria Cusí; Mariona Suñol; Teresa Toll; Belén Perez; Aida Ormazabal; Brian Fowler; Rafael Artuch
Journal:  JIMD Rep       Date:  2012-07-21

Review 3.  Pulmonary complications of sickle cell disease.

Authors:  Andrew C Miller; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2012-03-23       Impact factor: 21.405

4.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

5.  An unusual cause of hypertension with hematuria and proteinuria: Answers.

Authors:  Michael B Stokes; Ronald Zviti; Fangming Lin; Vivette D D'Agati
Journal:  Pediatr Nephrol       Date:  2016-03-15       Impact factor: 3.714

Review 6.  Current treatment of atypical hemolytic uremic syndrome.

Authors:  Bernard S Kaplan; Rebecca L Ruebner; Joann M Spinale; Lawrence Copelovitch
Journal:  Intractable Rare Dis Res       Date:  2014-05

7.  Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data.

Authors:  M Huemer; C Bürer; P Ješina; V Kožich; M A Landolt; T Suormala; B Fowler; P Augoustides-Savvopoulou; E Blair; K Brennerova; A Broomfield; L De Meirleir; G Gökcay; J Hennermann; P Jardine; J Koch; S Lorenzl; A S Lotz-Havla; J Noss; R Parini; H Peters; B Plecko; F J Ramos; A Schlune; K Tsiakas; M Zerjav Tansek; M R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2014-12-20       Impact factor: 4.982

8.  Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease.

Authors:  Roberto F Machado; A Kyle Mack; Sabrina Martyr; Christopher Barnett; Peter Macarthur; Vandana Sachdev; Inez Ernst; Lori A Hunter; Wynona A Coles; James P Nichols; Gregory J Kato; Mark T Gladwin
Journal:  Br J Haematol       Date:  2006-12-08       Impact factor: 6.998

9.  The roles of homocysteinemia and methylmalonic acidemia in kidney injury in atypical hemolytic uremic syndrome caused by cobalamin C deficiency.

Authors:  William D Wood; Ayah Elmaghrabi; Garrett Gotway; Matthias T F Wolf
Journal:  Pediatr Nephrol       Date:  2021-12-02       Impact factor: 3.651

10.  Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder.

Authors:  Ajay P Sharma; Cheryl R Greenberg; Asuri N Prasad; Chitra Prasad
Journal:  Pediatr Nephrol       Date:  2007-09-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.